| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7517334 | LILLY | Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose |
Mar, 2025
(1 year, 5 months from now) | |
Forteo is owned by Lilly.
Forteo contains Teriparatide.
Forteo has a total of 1 drug patent out of which 0 drug patents have expired.
Forteo was authorised for market use on 26 November, 2002.
Forteo is available in solution;subcutaneous dosage forms.
The generics of Forteo are possible to be released after 25 March, 2025.
Drugs and Companies using TERIPARATIDE ingredient
Market Authorisation Date: 26 November, 2002
Treatment: NA
Dosage: SOLUTION;SUBCUTANEOUS
How can I launch a generic of FORTEO before it's drug patent expiration?
More Information on Dosage
FORTEO family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic